Author

Andrew R. Nager

Pfizer (United States)ORCID 0000-0002-2909-9767Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Akshata Udyavar· 1 shared Alexandra Stevens· 1 shared Amy Carr· 1 shared Anagha Deshpande· 1 shared Aniruddha J. DeshpandeiD· 1 shared Benjamin A. Garcia· 1 shared Cameron J. DouglasiD· 1 shared Cho-Ying ChiangiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Akshata Udyavar

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Photoproximity labeling of c-Myc reveals SLK as a cancer specific co-regulator

Ryan R. Milione, Feifei Tong, Kristine Wolfe, Cameron J. Douglas, Sara B. Linker, Xinmeng Jasmine Mu, James V. Oakley, Andrew R. Nager, Michalina Janiszewska, Ciaran P. Seath

The paper identifies SLK as a cancer-specific co-regulator of c-Myc using photoproximity labeling, showing it stabilizes c-Myc and drives tumorigenesis through splicing changes.

Nature Chemical Biology · Aug 13, 2026Peer-reviewedCancer Biology

Disrupting a Convergent Acetylation Circuit Collapses Leukemic Identity Across AML Subtypes

Anagha Deshpande, Cho-Ying Chiang, Marlenne Perales, Neha Niranjan, Neelam Sinha, Darren Finlay, Alexandra Stevens, Emily Zahn, Benjamin A. Garcia, Irmela Jeremias, Mark Wunderlich, Kristen Jensen-Pergakes, Akshata Udyavar, Amy Carr, Andrew R. Nager, , Aniruddha J. Deshpande

This paper identifies an acetylation-dependent circuit controlling SEC integrity in AML, showing that disrupting KAT2A/B leads to broad anti-leukemic effects across subtypes.

bioRxiv · Jul 14, 2026 · PreprintCancer Biology